The landscape of clinical trials is undergoing a significant transformation, driven by advancements in technology and innovation. This webinar aims to explore the profound impact of these developments on the regulatory framework governing clinical trials. In recent years, technology has revolutionized various aspects of clinical trials, including patient recruitment, data collection, monitoring, and analysis. The integration of electronic health records, wearable devices and mobile applications has streamlined the recruitment process, enabling researchers to reach a larger and more diverse pool of participants. Moreover, these technological advancements have facilitated real-time data collection, enhancing the accuracy and efficiency of clinical trial outcomes.
The emergence of innovative methodologies, such as adaptive trial designs and virtual trials, has also challenged traditional regulatory approaches.
This webinar will:
- Delve into the regulatory implications of these technological and innovative advancements.
- Explore how regulatory bodies are adapting to these changes, ensuring patient safety and data integrity while ethical considerations are upheld.
- Uncover challenges faced by regulators in keeping pace with rapidly evolving technologies while maintaining robust oversight and compliance.
- Join this webinar to gain valuable insights from industry experts and regulatory authorities and discover strategies to navigate the evolving regulatory environment successfully.
Speakers:
Trang Gisler, Senior Director, Strategy, Government and Public Health Services, PPD Clinical Research Business, Thermo Fisher Scientific
Carlos Peña, PhD, MS, Chief Regulatory Officer and Chief Quality Officer, Jacobs Institute
